AstraZeneca

AstraZeneca 'provided' outdated vax data for trial: Top US agency

US-based National Institute of Allergy and Infectious Diseases (NIAID) expressed concern on Tuesday that British-Swedish pharmaceutical major AstraZeneca may have provided outdated information on the efficacy data related to the clinical trial of its Covid-19 vaccine, which may have provided an incomplete view of the efficacy data. Mar 23, 2021
AstraZeneca

AstraZeneca Vaccine Found 79% Effective In US Trials

The vaccine was 100% effective against severe or critical disease and hospitalisation and was safe, the drugmaker said on Monday, releasing results of the late-stage human trial study of more than 32,000 volunteers across all age groups. Mar 22, 2021
Covid vaccine

Covid-19 vaccination -- A handy guide for all your queries

We have entered the second phase of the worlds largest immunisation programme. However, several looming questions could hamper the success of this programme and weaken the fight against Covid-19, says Dr Rahul Pandit, giving a list of guidelines to follow amid the vaccination drive. Mar 18, 2021